Medical and social status of "hopeless" drug resistant TB cases

A. L. Khanin, I. B. Viktorova, S. A. Dolgikh, V. D. Gidetzkaya (Novokuznetsk, Russian Federation)

Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Session: Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Session type: Electronic Poster Discussion
Number: 4126
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. L. Khanin, I. B. Viktorova, S. A. Dolgikh, V. D. Gidetzkaya (Novokuznetsk, Russian Federation). Medical and social status of "hopeless" drug resistant TB cases. Eur Respir J 2007; 30: Suppl. 51, 4126

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020


"Adolescent smoking cessation-2005" in Romania – outcomes and plans for the future
Source: Eur Respir J 2006; 28: Suppl. 50, 474s
Year: 2006

"INSPIRAÇÃO" study: a self description of severity, burden and health status in COPD patients in Portugal
Source: Eur Respir J 2006; 28: Suppl. 50, 809s
Year: 2006

Social problems of drug resistant tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 15s
Year: 2006

Is there a need for prolonged follow up in mono-drug resistant TB?
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Notified or missed cases? An assessment of successful linkage for referred tuberculosis patients in South India
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015

A course to teach medical students in counselling smokers: evaluation of the effects on "knowledge", "skills" and "attitudes"
Source: Eur Respir J 2007; 30: Suppl. 51, 164s
Year: 2007

Do we need to screen for latent TB when initiating a methotrexate treatment?
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Impact of social support programme on MDR-TB patients' treatment outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Social determinants of drug-susceptible and drug resistant tuberculosis
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosis
Source: Eur Respir J 2014; 44: 5-7
Year: 2014


High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Fulfillment results of national program "tuberculosis" in penitentiary institutions of Belarus
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004

Managing difficult TB cases: experiences from the ERS/WHO TB Consilium and other country-specific Consilia
Source: International Congress 2017 – In the frontline of the fight against tuberculosis
Year: 2017


Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario
Source: Eur Respir J 2006; 28: Suppl. 50, 858s
Year: 2006

Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Four cases, one family: A cluster of resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016